AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. They are redefining interventional therapy for severely calcified lesions with their Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. 

Manufacturing

Medical Devices

AVS' headquarters in Ann Arbor, MI, United States

This department focuses on innovating and developing new products and technologies.

Research and Development

The Board and Advisory Roles team at AVS consists of experienced professionals who provide strategic guidance and industry insights to drive the company’s vision and growth. This team collaborates with executive leadership to navigate regulatory challenges, optimize product development, and establish partnerships, ensuring that AVS remains at the forefront of innovation in treating severely calcified arterial disease. Their expertise supports informed decision-making and facilitates the successful launch and adoption of the Pulse IVL System in the market.

Board and Advisory Roles

The Leadership Team at AVS drives the strategic vision and operational execution of the company, guiding the development and commercialization of the Pulse IVL System. Comprising executives from engineering, operations, and marketing backgrounds, they collaborate to ensure innovation in product design, foster a strong company culture, and navigate the regulatory landscape unique to medical device development, all while maintaining a steadfast focus on improving patient outcomes in interventional cardiology.

Leadership Team

The Engineering Team at AVS is responsible for the design, development, and refinement of innovative medical devices, specifically the Pulse IVL System. This team collaborates on creating cutting-edge engineering solutions to effectively treat severely calcified arterial disease, ensuring the device meets stringent safety and efficacy standards. Their diverse expertise in research and development, systems engineering, and product design drives the advancement of interventional therapy technologies within the company.

Engineering Team

The Quality Assurance and Regulatory Affairs team at AVS is responsible for ensuring that the Pulse IVL System meets stringent safety and efficacy standards throughout its development and commercialization. This team conducts thorough testing, develops and implements quality management systems, and navigates regulatory requirements to ensure compliance with medical device regulations. Additionally, they support clinical trials by overseeing quality controls and documentation, thereby facilitating successful product approval and market entry.

Quality Assurance and Regulatory Affairs

This department oversees clinical operations and strategies to ensure the effectiveness and compliance of healthcare-related initiatives.

��

People (3)

Jobs (0)

Other teams

Board and Advisory Roles

Leadership Team

Engineering Team

Quality Assurance and Regulatory Affairs

Clinical Affairs

��������

People (3)

Jobs (0)

Other teams

Board and Advisory Roles

Leadership Team

Engineering Team

Quality Assurance and Regulatory Affairs

Clinical Affairs

��